BRI3BP Knockout HAP1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population designed to disrupt the human BRI3BP gene, generating a loss-of-function model for investigating the role of BRI3BP in mitochondrial apoptosis and cellular stress responses. This pooled population of gene-edited HAP1 cells provides a genetically defined system for studying apoptotic signaling without the confounding effects of clonal selection, making it suitable for robust functional studies where polyclonal representation is desired.
The parental HAP1 cell line is a near-haploid, adherent fibroblast-like line derived from a male patient with chronic myeloid leukemia (CML) and carries the Philadelphia chromosome (BCR-ABL1 fusion). Its haploid nature facilitates efficient gene disruption and simplifies genetic analysis, establishing HAP1 as a widely used model in haploid genetic screening and cancer research. This background offers a physiologically relevant context for examining apoptosis pathways in a leukemia-derived cell type.
BRI3BP encodes a mitochondrial protein that functions as an interacting partner of BRI3, and the BRI3BP-BRI3 complex is implicated in the regulation of apoptotic signaling. The BRI3BP network operates downstream of p53 (TP53) and DNA damage responses, converging on mitochondrial outer membrane permeabilization controlled by BCL2 family members. Specifically, BRI3BP interacts with BCL-XL (BCL2L1) and is linked to the release of cytochrome c and the activation of executioner caspases, including caspase-3 (CASP3). Disruption of BRI3BP may alter the balance between pro-survival and pro-apoptotic factors, such as BAX, thereby modulating the intrinsic apoptosis pathway.
In HAP1 cells, which are inherently primed for apoptosis due to their leukemic origin and chromosomal aberrations, knockout of BRI3BP provides a tractable model for dissecting mitochondrial dysfunction and apoptotic sensitivity. This system allows researchers to evaluate how loss of BRI3BP influences the cellular response to genotoxic stress or targeted therapies, potentially revealing synthetic lethal interactions or novel regulatory nodes within the BCL2 family network. The near-haploid state simplifies interpretation of phenotypic changes stemming from gene disruption, enabling clean genotype-phenotype correlations.
Key applications of these polyclonal knockout cells include apoptosis research, cancer cell biology, functional genomics, and drug target validation. Researchers can assess apoptosis by measuring cleaved caspase-3 via western blotting, quantifying phosphatidylserine exposure with annexin V flow cytometry, monitoring cytochrome c release from mitochondria, or evaluating mitochondrial membrane potential using JC-1 dye. These assays enable detailed investigation of mitochondrial integrity and cell death execution. For further information, please contact Ascent Research.
